-
March 31,2025
Press release
FUNPEP and BIOASTER are signing a strategic agreement to optimize an in vitro assay to induce a human B cell immune response to FUNPEP leading candidates. [PDF file]
-
March 12,2025
Press release
Commencement of Allergy Vaccine Clinical Trial [PDF file]
-
December 23,2024
Press release
Commencement of an Additional Phase III Clinical Trial of the functional peptide SR-0379 [PDF file]
-
August 21,2024
Press release
Notice Concerning Progress on Research on Next-Generation Formulation Technology for Antibody-Inducing Peptides [PDF file]
-
March 4,2024
Press release
Announcement of Option Agreement between FunPep and SHIONOGI Regarding Allergy Vaccine [PDF file]
-
November 27,2023
Press release
Notice Concerning Commencement of Research on Alzheimer’s Disease Vaccine [PDF file]
-
August 24,2023
Press release
Exercise of Option by MEDIPAL HOLDINGS CORPORATION [PDF file]
-
June 13,2023
Press release
Announcement of Newly Developed Compound for Antibody-Inducing Peptide against Pollinosis [PDF file]
-
February 14,2023
Press release
Announcement of Preliminary Results of Phase I/IIa Clinical Trial of Antibody Inducing Peptide FPP003 [PDF file]
-
November 22,2022
Press release
Announcement of Preliminary Results for the Phase III Clinical Trial of Functional Peptide SR-0379 [PDF file]